Tag: Zydus Lifesciences

Zydus Lifesciences shares rose nearly 1% on September 21 after the company received final approval from the USFDA for Clindamycin Phosphate Gel USP, a skincare gel used to treat acne. The drug will be manufactured at the group’s topical manufacturing facility at Changodar, Ahmedabad. This is the latest in a series of approvals for Zydus Lifesciences from the USFDA. The company is expected to continue to do well in its current business operations, with new drivers for growth based on vaccines, biosimilars, and complex generics.

Tata Motors, Biocon, RR Kabel, BHEL, Wipro, Prakash Industries, Blue Star, LTIMindtree, BL Kashyap and Sons, NBCC (India), HDFC Bank, JK Lakshmi Cement, Zydus Lifesciences, Sasken Technologies, DCM Shriram, Jindal Steel & Power, Union Bank of India, Central Bank of India, Indian Railway Finance Corporation, and ADF Foods announce various business updates, including new appointments, partnerships, product launches, and investments.

The Indian stock market is expected to continue its upward momentum in the coming weeks, with the Nifty50 index likely to touch the 20,000 mark. Here are the top 10 trading ideas for the next 3-4 weeks, based on technical analysis.